IL97933A - Monoclonal antibodies to porcine somatotropin and pharmaceutical compositions containing the same - Google Patents
Monoclonal antibodies to porcine somatotropin and pharmaceutical compositions containing the sameInfo
- Publication number
- IL97933A IL97933A IL9793391A IL9793391A IL97933A IL 97933 A IL97933 A IL 97933A IL 9793391 A IL9793391 A IL 9793391A IL 9793391 A IL9793391 A IL 9793391A IL 97933 A IL97933 A IL 97933A
- Authority
- IL
- Israel
- Prior art keywords
- pst
- somatotropin
- monoclonal antibody
- antibodies
- growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/521,695 US6165465A (en) | 1990-05-15 | 1990-05-15 | Immunologic enhancement of the somatogenic effect of somatotropin with an antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL97933A0 IL97933A0 (en) | 1992-06-21 |
| IL97933A true IL97933A (en) | 1995-08-31 |
Family
ID=24077752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9793391A IL97933A (en) | 1990-05-15 | 1991-04-24 | Monoclonal antibodies to porcine somatotropin and pharmaceutical compositions containing the same |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6165465A (de) |
| EP (1) | EP0458072B1 (de) |
| JP (1) | JPH04228091A (de) |
| KR (1) | KR910019639A (de) |
| AT (1) | ATE127849T1 (de) |
| AU (1) | AU648303B2 (de) |
| CA (1) | CA2042437A1 (de) |
| DE (1) | DE69112904T2 (de) |
| DK (1) | DK0458072T3 (de) |
| ES (1) | ES2076399T3 (de) |
| FI (1) | FI98828C (de) |
| GR (1) | GR3017412T3 (de) |
| IE (1) | IE69575B1 (de) |
| IL (1) | IL97933A (de) |
| NO (1) | NO911877L (de) |
| NZ (1) | NZ238070A (de) |
| PT (1) | PT97650B (de) |
| ZA (1) | ZA913646B (de) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341012C (en) * | 1982-09-27 | 2000-06-06 | Biogen, Inc. | Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides |
| AU2092983A (en) * | 1982-11-08 | 1984-05-17 | Genentech Inc. | Porcine growth hormone produced by recombinant dna technology |
| US4925922A (en) * | 1983-02-22 | 1990-05-15 | Xoma Corporation | Potentiation of cytotoxic conjugates |
| CA1259923A (en) * | 1983-08-17 | 1989-09-26 | Roger Aston | Physiologically active compositions |
| US4599229A (en) * | 1985-09-09 | 1986-07-08 | International Minerals & Chemical Corp. | Method of promoting animal growth using antibodies against somatostatin |
| US4764475A (en) * | 1986-12-01 | 1988-08-16 | The University Of British Columbia | Pancreas dependant immunoassay for determining subpopulations of monoclonal antibodies to somatostatin. |
| GB8707398D0 (en) * | 1987-03-27 | 1987-04-29 | Coopers Animal Health | Biologically active molecules |
| FI900075L (fi) * | 1987-07-06 | 1990-01-05 | Peptide Technology Ltd | Medvaexthormon bindande peptid. |
| GB8718937D0 (en) * | 1987-08-11 | 1987-09-16 | Coopers Animal Health | Biologically active molecules |
| NZ225760A (en) * | 1987-08-14 | 1991-02-26 | Bio Technology General Corp | Expression plasmids containing the deo promoter and bacterial hosts containing these plasmids |
| US4837202A (en) * | 1987-09-14 | 1989-06-06 | Pitman-Moore, Inc. | Method for stimulating the immune system |
| DK8189A (da) * | 1988-01-12 | 1989-07-13 | Bunge Australia | Antigen-antistof-konjugater, deres fremstilling og anvendelse |
-
1990
- 1990-05-15 US US07/521,695 patent/US6165465A/en not_active Expired - Fee Related
-
1991
- 1991-04-10 IE IE119891A patent/IE69575B1/en not_active IP Right Cessation
- 1991-04-22 DK DK91106423.6T patent/DK0458072T3/da active
- 1991-04-22 AT AT91106423T patent/ATE127849T1/de not_active IP Right Cessation
- 1991-04-22 ES ES91106423T patent/ES2076399T3/es not_active Expired - Lifetime
- 1991-04-22 DE DE69112904T patent/DE69112904T2/de not_active Expired - Fee Related
- 1991-04-22 EP EP91106423A patent/EP0458072B1/de not_active Expired - Lifetime
- 1991-04-24 IL IL9793391A patent/IL97933A/en not_active IP Right Cessation
- 1991-04-29 AU AU76064/91A patent/AU648303B2/en not_active Ceased
- 1991-05-07 NZ NZ238070A patent/NZ238070A/xx unknown
- 1991-05-13 JP JP3135262A patent/JPH04228091A/ja active Pending
- 1991-05-13 CA CA002042437A patent/CA2042437A1/en not_active Abandoned
- 1991-05-14 KR KR1019910007773A patent/KR910019639A/ko not_active Ceased
- 1991-05-14 PT PT97650A patent/PT97650B/pt not_active IP Right Cessation
- 1991-05-14 ZA ZA913646A patent/ZA913646B/xx unknown
- 1991-05-14 FI FI912341A patent/FI98828C/fi active
- 1991-05-14 NO NO91911877A patent/NO911877L/no unknown
-
1995
- 1995-09-14 GR GR950401504T patent/GR3017412T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3017412T3 (en) | 1995-12-31 |
| DE69112904D1 (de) | 1995-10-19 |
| EP0458072B1 (de) | 1995-09-13 |
| ATE127849T1 (de) | 1995-09-15 |
| FI912341L (fi) | 1991-11-16 |
| KR910019639A (ko) | 1991-12-19 |
| PT97650B (pt) | 1998-08-31 |
| ZA913646B (en) | 1992-02-26 |
| JPH04228091A (ja) | 1992-08-18 |
| CA2042437A1 (en) | 1991-11-16 |
| AU7606491A (en) | 1991-11-21 |
| EP0458072A1 (de) | 1991-11-27 |
| FI912341A0 (fi) | 1991-05-14 |
| AU648303B2 (en) | 1994-04-21 |
| NO911877D0 (no) | 1991-05-14 |
| NZ238070A (en) | 1993-08-26 |
| DK0458072T3 (da) | 1995-11-13 |
| US6165465A (en) | 2000-12-26 |
| FI98828C (fi) | 1997-08-25 |
| IE911198A1 (en) | 1991-11-20 |
| IE69575B1 (en) | 1996-10-02 |
| PT97650A (pt) | 1992-03-31 |
| ES2076399T3 (es) | 1995-11-01 |
| NO911877L (no) | 1991-11-18 |
| DE69112904T2 (de) | 1996-05-15 |
| FI98828B (fi) | 1997-05-15 |
| IL97933A0 (en) | 1992-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6419928B1 (en) | Monoclonal antibodies to transforming growth factor-beta and methods of use | |
| US4864019A (en) | Antibodies to inhibin and conjugates produced therefrom | |
| SK635290A3 (en) | Polypeptide, subsequences thereof and their use | |
| US4652629A (en) | Synthetic peptide-based anti-rabies compositions and methods | |
| CA1259923A (en) | Physiologically active compositions | |
| HUT52787A (en) | Process for production of biologically active peptides | |
| US5210180A (en) | Enhancement of porcine somatotropin activity | |
| US6165465A (en) | Immunologic enhancement of the somatogenic effect of somatotropin with an antibody | |
| EP0502416B1 (de) | Wachstumsstimulierung durch antiidiotypische Antikörper erzeugt gegen einen für Schweinewachstumshormon spezifischen Antikörper | |
| Thorpe et al. | Single shot intrasplenic immunization: an advantageous procedure for production of monoclonal antibodies specific for human fibrin fragments | |
| AU704010B2 (en) | Novel peptides useful in enhancement of FSH action | |
| KR940005665A (ko) | 분리된 폴리펩티드, 이를 암호하는 핵산 분자, 상기 폴리펩티드를 포함하는 조성물 및 이를 사용하는 방법 | |
| HUT52788A (en) | Process for production of biologically active peptides and antigene medical compositions containing these peptides as active substance | |
| Capiaumont et al. | Assay of a seric human hexapeptide (HWESAS) using a monoclonal antibody and ELISA | |
| US4707356A (en) | Synthetic peptide-based anti-rabies compositions and methods | |
| US5066593A (en) | Synthetic peptide-based anti-rabies compositions and methods | |
| CA2026803A1 (en) | Monoclonal antibody to exotoxin a of pseudomonas aeruginosa | |
| Yamazaki et al. | Preparation of monoclonal antibodies to chicken bone phosphoproteins | |
| Zhang et al. | Modulation of the Effectiveness of Growth Hormone with a Monoclonal Antibody. | |
| del Guercio et al. | B-lymphocyte regulation of the immune system: III. Preparation and characterization of rabbit antibodies that inhibit the biological activity of the lymphokine, B-cell-derived enhancing factor (BEF) | |
| Murgita | Studies on the control of antibody formation: the effect of passively administered antibody on the primary immune response. | |
| JPH03128329A (ja) | 虚血性心疾患の予防・治療剤 | |
| JPH11302193A (ja) | 血管新生阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |